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Abstract
Background: The pathophysiological changes occurring in the trabecular meshwork in primary open angle
glaucoma are poorly understood, but are thought to include increased extracellular matrix deposition, trabecular
meshwork cell apoptosis, inflammation, trabecular meshwork calcification and altered protein composition of the
aqueous humor. Although many proteins are present in aqueous humor, relatively few have been studied
extensively, and their potential roles in primary open angle glaucoma are unknown.
Methods: Analyte concentrations in aqueous humor from 19 primary open angle glaucoma and 18 cataract patients
were measured using a multiplex immunoassay. Fisher’s exact test was used to assess statistical significance between
groups, and correlations of analyte concentrations with age, intraocular pressure, pattern standard deviation, mean
deviation, cup-to-disc ratio and disease duration since commencing treatment were tested by Spearman’s method.
Results: CHI3L1, FLRG, HGF, MIF, P-selectin and Uteroglobin were detected in more than 50% of samples of one or
both patient groups, some of which have not previously been quantified in aqueous humor. In the glaucoma but not
the cataract group, significant correlations were determined with age for Uteroglobin/SCGB1A1 (rs = 0.805, p < 0.0001)
and FLRG (rs = 0.706, p = 0.0007). Furthermore, HGF correlated significantly with disease duration (rs = − 0.723,
p = 0.0007). There were no differences in analyte concentrations between groups, and no other significant associations
with clinical descriptors that passed correction for multiple testing.
Conclusions: The correlations of uteroglobin and FLRG with age in primary open angle glaucoma but not cataract
may suggest a heightened requirement for anti-inflammatory (uteroglobin) or anti-calcification (FLRG) activity in the
ageing glaucomatous trabecular meshwork.
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Background
Aqueous humor is a clear fluid that circulates throughout
the anterior chamber of the eye to provide nutrients to
and remove metabolic waste products from the tissues it
contacts, and thus contributes to the maintenance of nor-
mal eye function [1]. The majority of aqueous humor
drains from the eye via the trabecular meshwork (TM), a
specialised porous tissue responsible for the regulation of
intraocular pressure (IOP) [2]. In primary open angle
glaucoma (POAG), decreased drainage of aqueous humor
through a compromised TM leads to elevated IOP [1],
causing optic nerve degeneration and thus a progressive
loss of peripheral vision unless treated. Elevated IOP is the
only modifiable risk factor for the development of glau-
coma, and all current treatments for POAG are aimed at
reducing IOP [2].
The molecular and cellular changes that contribute to
TM dysfunction and elevated IOP in POAG are poorly
understood. Several processes, including altered extracel-
lular matrix (ECM) turnover [3], oxidative stress [4], in-
flammation [5], reduced TM cellularity [6], increased TM
stiffness [7] and TM calcification [8] are all potential con-
tributors to the pathological changes occurring in the TM
during POAG. Many clinical studies of glaucomatous
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aqueous humor samples have reported alterations of mul-
tiple inflammatory mediators, including TGF- β2 [9–11],
IL-8 [12], IL12, IFNγ and CXCL9 [13, 14] compared to
controls, and a pro-inflammatory environment of the
aqueous humor has been reported for an animal model of
glaucoma [15]. Furthermore, inflammation can cause TM
cell apoptosis and lead to a dysfunctional trabecular
meshwork, thus contributing to an elevated IOP [5].
Whilst many proteins have been detected in aqueous
humor using discovery-based proteomics approaches
[16–22], no detailed studies have been performed with
regards to these proteins, and thus any potential role in
eye physiology or diseases such as glaucoma remains un-
determined. Increased knowledge of the proteins present
in aqueous humor from POAG patients may provide
clues to improve our understanding of the disease pro-
cesses involved and how they interact with each other.
Accordingly, the aims of this study were to compare the
concentrations of selected proteins from these studies, in-
cluding several not previously analysed in eye diseases, in
aqueous humor samples obtained from a well-defined co-
hort of 19 POAG patients against 18 non-glaucomatous
cataract samples. Subsequently, we sought to determine
the extent of correlation between each of these proteins
and relevant clinical descriptors including age, IOP,
field of vision (quantified by Humphrey’s visual field
pattern standard deviation (PSD) score and mean devi-
ation (MD)), optic cup/disc ratio (CDR) and disease dur-
ation since commencing treatment. Here, we report the
concentrations of six aqueous humor proteins, and iden-
tify significant correlations of age with Uteroglobin and
FLRG specific to the POAG group, as well as a correlation
of HGF with POAG disease duration.
Methods
Patient eligibility and recruitment: This study was ap-
proved by the Health and Medical Human Research Ethics
Committee Tasmania (H0013264), and executed in adher-
ence to the tenets of the Declaration of Helsinki. All par-
ticipants were recruited through Tze’Yo Toh at the
Launceston Eye Institute and gave written consent with
regards to donation and use of aqueous humor samples.
POAG was diagnosed based on characteristic optic disc
cupping, corresponding visual field loss, and retinal nerve
fibre layer thinning, regardless of the presenting IOP. The
anatomy of the drainage angle was assessed by gonio-
scopic examination. Non-glaucomatous cataract patients
(referred to herein as the cataract group) were recruited to
serve as a control for this study. POAG patients who had
previously had a trabeculectomy or vitrectomy were ex-
cluded from this study. Furthermore, POAG and cataract
subjects were excluded if they had other retinal (such as
diabetic retinopathy or age-related macular degeneration)
or neurological disease.
Clinical descriptors including age, IOP and CDR were
recorded for both patient groups. IOP was measured in
all patients using a calibrated Goldmann Applanation
tonometer. For POAG patients, only the latest treated
IOP measurement taken during the consultation prior to
the surgery was used for this study. Vertical CDR was
estimated by one observer (Tze’Yo Toh), using a 60D
lens during indirect slit lamp fundoscopy and further
confirmed with an optic disc profile scan using Ocular
Coherence Tomography. MD and PSD were included as
measures for vision loss, but were not available for all
patients (MD was recorded for 13/19 POAG and 5/18
cataract patients, PSD for 19/19 POAG and 6/18 cataract
patients). Furthermore, disease duration since commen-
cing treatment was noted for POAG patients at the time
AH samples were collected.
All POAG patients recruited were receiving IOP-
lowering eye drops, in the form of monotherapy, or a
combination of up to four of the following compounds:
Timolol (beta-blocker), Bimatoprost, Tafluprost, Latano-
prost, Travoprost (prostaglandin derivatives), Brimonidine
(alpha 2 agonist) and Brinzolamide (carbonic anhydrase
inhibitor).
Aqueous humor collection: Aqueous humor samples
(50–100 μL) were collected from 19 patients with POAG
during routine cataract surgery. Aqueous humor was also
collected from 18 non-glaucomatous patients undergoing
routine cataract surgery to serve as a control for this study
[16, 23]. For all samples, aqueous humor was collected
from the centre of the anterior chamber by paracentesis at
the beginning of surgery, immediately frozen at − 20 °C,
and transferred to − 80 °C within 48 h, where they were
stored for analysis.
Multiplex immunoassay: We used discovery-based
proteomic studies of AH in combination with other rele-
vant scientific literature to select 30 proteins for inclusion
in a custom magnetic bead-based multiplex immunoassay
(R&D Systems, Inc., Minneapolis, MN) to enable simultan-
eous measurement of each protein in aqueous humor sam-
ples. The 30 proteins included were: Angiopoietin-1,
Angiopoietin-2, BMP-2, BMP-4, BMP-9, CCL27/CTACK,
CHI3L1/YKL-40, Collagen IV alpha 1, Cripto-1, DcR3,
EGF, Endoglin/CD105, Endothelin-1, Epo, FLRG, Follistatin,
Growth Hormone, HGF, IGFBP-1, IGFBP-3, IL-6, IL-9, LIF,
MFG-E8, MIF, P-Selectin, Thrombospondin-2, Uteroglobin,
VCAM-1 and vWF-A2. Some of these proteins (endothelin-
1, HGF, EPO, MIF) have previously been shown to be
present in aqueous humor using immunoassay techniques,
but there are scant or no subsequent studies reporting
correlation to clinical descriptors [12, 24–28]. Others
(e.g. thromobospondin-2, follistatin) have been shown to
be altered in animal [29] or cell culture-based [30] models
of glaucoma, but there are no reports of their levels in
aqueous humor. We also selected several proteins (e.g.
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CHI3L1, CTACK, Cripto-1, DcR3, Endoglin, uteroglobin,
FLRG, MFG-E8, P-selectin) that have been identified as
being present in aqueous humor, but for which there is a
paucity of studies characterising their involvement in
glaucoma.
The assay was performed in accordance with manufac-
turer's instructions on a Bio-Plex 200 System (Bio-Rad
Laboratories, Inc., Hercules, CA). Aqueous humor dilu-
tions with assay diluent were kept to a minimum, with
dilution factors ranging from 1.5–5.5, sufficient to allow
loading of 50 μl of diluted sample per assay well. Fluor-
escence intensity (FI) was measured and analysed using
Bio-Plex Manager 6.0. The majority of concentrations
out of range were below the detection limit for the rele-
vant analyte, with the exception of MIF, which resulted
in FIs above the highest standard for two cataract and
three POAG samples. Readings out of range of the
standard curve were excluded from all subsequent ana-
lyses. The concentration ranges of the standard curves
and the number of samples in range for each analyte
tested are given in Additional file 1: Table S1.
Normalisation to total protein concentration: Total aque-
ous humor protein concentration was measured using a
BCA protein assay (Thermo Fisher Scientific, Waltham,
MA). Aqueous humor samples were diluted 6-fold in ultra-
pure water and assessed as described in the manufacturer’s
protocol. Individual analyte concentrations were normal-
ised to total protein concentration for each sample prior to
calculation of correlations as described below.
Statistical analyses: All statistical analyses were con-
ducted with Prism 7 (GraphPad Software, San Diego, CA),
using unpaired two-tailed tests with a significance thresh-
old of p = 0.05. Differences in age, IOP, CDR and total
protein concentration were assessed using unpaired T-
tests, MD and PSD were evaluated with Mann-Whitney U
tests due to non-Gaussian data distribution, and gender
was tested using Fisher’s exact test. Analyte concentra-
tions measured for POAG and cataract samples were
grouped and the number of samples within range versus
out of range of the standard curve were compared using
Fisher’s exact test. Due to the non-normal distributions
obtained for some analyte data sets, correlations with clin-
ical descriptors were calculated using the non-parametric
Spearman’s method (rs: Spearman’s correlation coefficient).
To minimise identification of false associations in our data,
Bonferroni’s method was used to correct for multiple test-
ing of the analyte concentration data set across different
analyses, resulting in an adjusted significance threshold of
p = 0.0017 (conventional threshold of 0.05/30 protein ana-
lytes = adjusted threshold of p = 0.0017).
Results
In this study, aqueous humor samples from 19 POAG and
18 non-glaucomatous cataract patients were analysed using
a multiplex assay, to quantify the concentrations of 30 pro-
teins reported to be present in aqueous humor [16, 17].
Clinical descriptors including age, IOP and CDR were col-
lected for all patients and are presented in Table 1. MD
and PSD were included as measures of vision loss; how-
ever, MD data was only available for 13 POAG and 5 cata-
ract patients, and PSD for 6 cataract patients (Table 1). In
addition, disease duration since commencing treatment
was recorded for the POAG group (Table 1). There were
no significant differences between cataract and POAG
groups with regards to age (p = 0.335), gender (p = 0.313),
IOP (p = 0.783) or total aqueous protein concentration
(p = 0.077). Whilst the differences in MD and PSD were
also non-significant (p = 0.846 and p = 0.0818, respect-
ively), this is likely due to the lack of data for the majority
of cataract patients. The difference in CDR was statistically
significant, with a mean CDR of 0.78 in POAG compared
to 0.40 in the cataract group (p < 0.0001). All patients in
the POAG cohort were receiving IOP-lowering medication,
with 63% (12/19) on a monotherapy regime of one prosta-
glandin derivative. The remaining patients received a com-
bination of up to four compounds. All POAG patients were
treated with a prostaglandin derivative, and 32% (6/19)
were simultaneously prescribed with Timolol (β-blocker). A
small percentage of patients received an α2-agonist (1/19)
and/or a carbonic anhydrase inhibitor (2/19) in addition
to the prostaglandin derivative and β-blocker. In this ini-
tial study, we have not attempted to assess differences in
analyte concentrations due to specific medication regimes.
Out of the 30 proteins tested, 6 were detectable in ≥50%
of samples in one or both groups: CHI3L1, FLRG, HGF,
MIF, P-selectin and Uteroglobin (Table 2). The remaining
24 analytes were either not detected, or detected in only a
small number of samples, and were therefore excluded from
all subsequent analyses (see Additional file 1: Table S1). Of
those proteins analysed further, CHI3L1 was present at the
highest levels, with median concentrations above 65 ng/ml.
FLRG and MIF were detected at intermediate levels, with
median concentrations ranging from 3.6 to 6 ng/ml,
whereas HGF, P-selectin and Uteroglobin were all quantified
at median concentrations below 1 ng/ml.
The number of samples in range versus below the range
of the standard curve were compared for each analyte using
Fisher’s exact test. Whilst analysis revealed a difference for
HGF (p = 0.003) between cataract (9/18 in range) and
POAG (18/19 in range), the result did not pass correction
for multiple testing (adjusted p-value threshold = 0.0017).
In addition, no sample was consistently below the 5th or
above the 95th percentile for all analytes reported.
Significant correlation of FLRG and uteroglobin with age
in POAG but not cataract
Prior to calculating correlations, analyte concentrations
were normalised using total aqueous humor protein
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concentration. The total protein concentrations deter-
mined for POAG and cataract samples (mean concentra-
tions of 3.77 and 3.21 mg/ml, respectively) did not differ
significantly between groups (p = 0.077). Similarly, nor-
malised analyte concentrations did not differ signifi-
cantly between the POAG and cataract group (Fig. 1).
Correlations between normalised analyte concentrations
and age were assessed for both patient groups (Table 3).
Significant positive correlations were obtained with FLRG
(rs = 0.706, p = 0.0007) and Uteroglobin (rs = 0.805, p <
0.0001) for POAG but not the cataract group (rs = 0.475,
p = 0.065 and rs = 0.555, p = 0.022, respectively). Whilst fur-
ther correlations were determined for CHI3L1 (rs = 0.566,
p = 0.012) and HGF (rs = 0.642, p = 0.004) in POAG, these
did not pass correction for multiple testing. No significant
correlations were obtained between age and other analytes
(all p ≥ 0.05).
HGF correlated significantly with POAG disease duration
since commencing treatment
Analyte concentrations were also assessed for correlations
with CDR, IOP, PSD and MD for both patient groups, and
with disease duration since commencing treatment in
POAG only (Table 4 and Additional file 1: Tables S2-S5).
A significant correlation was determined between HGF
and disease duration (rs = − 0.723, p = 0.0007, Table 4).
Further correlations with disease duration were deter-
mined for CHI3L1 and FLRG (rs = − 0.555, p = 0.014 and
rs = − 0.673, p < 0.002, respectively, Table 4), and CHI3L1
correlated with CDR in cataract (rs = − 0.539, p = 0.021,
Additional file 1: Table S3), however, they did not pass
correction for multiple testing (adjusted p-value thresh-
old = 0.0017). No correlations were obtained between
IOP (Additional file 1: Table S2), MD (Additional file 1:
Table S4) or PSD (Additional file 1: Table S5) and any
analyte for either patient group.
Discussion
In this present study, aqueous humor samples were
collected and analysed from 19 POAG and 18 non-
glaucomatous cataract patients as controls. Out of the
30 analytes measured, 6 were quantified in sufficient sam-
ples to allow for further analysis (CHI3L1, FLRG, HGF,
MIF, P-selectin and Uteroglobin), some of which have not
previously been assessed with regards to eye physiology or
disease. The concentrations obtained for HGF and MIF
are consistent with existing literature [12, 26, 31] and to
the best of our knowledge, no quantitative measures of
CHI3L1, FLRG, P-selectin or Uteroglobin have been re-
ported in aqueous humor. Four of these proteins are dir-
ectly linked to inflammation: P-selectin and MIF are both
pro-inflammatory mediators, with P-selectin mediating
Table 1 Clinical data for non-glaucomatous cataract and POAG patients
Parameters Cataract POAG p-value
Age (years; Mean ± SD) 66.5 ± 7.0 68.9 ± 7.9 0.335
Sample number (M/F) 18 (5/13) 19 (9/10) 0.313
IOP (Mean, ± SD) 17.9 ± 3.5 17.6 ± 3.4 0.783
MD (Median, IQR) −3.1, −4.8 to − 0.9 − 3.6, − 4.8 to −2.0 0.846
PSD (Median, IQR) 1.63, 1.40–2.95 2.11, 1.69–5.26 0.082
CDR (Mean ± SD) 0.40, 0.22 0.78, 0.09 < 0.0001
Disease duration (years; Mean ± SD) N/A 2.59, 2.15 N/A
AH total protein (mg/ml; Mean ± SD) 3.21 ± 0.88 3.77 ± 0.97 0.077
POAG: Primary open angle glaucoma; SD: standard deviation; M: male; F: female; IOP: intraocular pressure in mmHg; MD: mean deviation; IQR: interquartile range;
PSD: Humphrey’s visual field pattern standard deviation; CDR: optic cup/disc ratio; N/A: not applicable; AH: aqueous humor. Statistical significance was assessed using
Fischer’s exact test (gender), unpaired T-test (age, IOP, CDR, total protein) and Mann-Whitney U-test (MD, PSD) with p < 0.05 considered significant (highlighted in bold)
Table 2 Aqueous humor analyte concentrations in non-glaucomatous cataract versus POAG
Cataract POAG
Analyte Median IQR In range Median IQR In range p-value
CHI3L1 65,171 53,191–91,124 18/18 83,122 65,958–95,018 19/19 1.000
FLRG 3614 2857–4412 16/18 4303 3679–5323 19/19 0.230
HGF 171.2 114–227 9/18 170.7 133–222 18/19 0.003
MIF 5592 4061–10,039 15/18 4809 3697–5830 15/19 1.000
P-selectin 791 691–874 9/18 927 803–1193 15/19 0.091
Uteroglobin 335 198–463 17/18 253 174–477 18/19 1.000
Median and interquartile range (IQR) calculated for data in range, reported as pg/ml. Significance was tested using the Fisher’s exact test for comparison of number of
detected vs. undetected samples in each group. Following correction for multiple testing using Bonferroni’s method, a p-value of < 0.0017 was considered significant
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leukocyte-endothelium adhesion [32], and MIF suppressing
the anti-inflammatory and immunosuppressive effects of
glucocorticoids [33]. CHI3L1 exerts its pro-inflammatory
effects at least in part by inhibiting apoptosis of T-cells,
macrophages and eosinophils [34]. In contrast, uteroglobin
has anti-inflammatory effects [35, 36]. Furthermore,
HGF is involved in tissue repair [26] and FLRG acts as
an inhibitor to members of the TGFβ superfamily [37].
Whilst no significant differences were found between
normalised analyte concentrations, significant correla-
tions of specific analytes with disease descriptors were
obtained, which are discussed below.
A positive correlation was determined for Uteroglobin
with age in POAG but not cataract samples, which may
indicate an increased need for anti-inflammatory activity
in the ageing glaucomatous TM. Uteroglobin is primarily
known for its association with various allergic and
inflammatory lung diseases [38], where it exerts an anti-
inflammatory effect by supressing various inflammatory
mediators, including INFγ, PLA2 and TNFα [35, 36]. In
addition, Uteroglobin plays a protective role against oxida-
tive stress [39]. In eosinophilic chronic rhinosinusitis, uter-
oglobin suppresses the expression of pro-inflammatory
CHI3L1 [40]. CHI3L1 is a commonly used TM cell marker
[41–43], although it is only expressed by TM cells in the
most anterior and posterior regions of the TM tissue [42],
which may reflect areas subject to the greatest levels of tis-
sue remodelling within the TM. Interestingly, in this study,
uteroglobin and CHI3L1 correlated in the POAG group
but not in the cataract group (POAG p = 0.006, rs = 0.624;
cataract p = 0.126, rs = 0.387), which may suggest that a
similar mechanism could be occurring in POAG, however,
this correlation did not pass correction for multiple testing.
Fig. 1 Normalised analyte distributions in cataract and primary open angle glaucoma (POAG) samples. Distribution of CHI3L1 (a), FLRG (b), HGF
(c), MIF (d), P-selectin (e) and Uteroglobin (f) concentrations in aqueous humor normalised to total aqueous humor protein concentration from
non-glaucomatous cataract (blue) and POAG (orange). Median and interquartile range are indicated
Table 3 Correlation of measured analytes to age for non-
glaucomatous cataract and POAG samples
Cataract POAG
Analyte rs p-value N rs p-value N
CHI3L1 −0.066 0.794 18 0.566 0.012 19
FLRG 0.475 0.065 16 0.706 0.0007 19
HGF 0.170 0.662 9 0.642 0.004 18
MIF 0.404 0.135 15 0.159 0.570 15
P-selectin −0.756 0.835 9 0.500 0.060 15
Uteroglobin 0.555 0.022 17 0.805 < 0.0001 18
Correlations of normalised analyte concentrations to age were determined using
Spearman’s rank correlation. Following correction for multiple testing using
Bonferroni’s method, a p-value of < 0.0017 was considered significant (highlighted
in bold). rs: Spearman correlation coefficient. N: number of correlation pairs
Table 4 Correlation of measured analytes to disease duration
for POAG samples
Disease duration*
Analyte rs p-value N
CHI3L1 −0.555 0.014 19
FLRG −0.673 0.002 19
HGF −0.723 0.0007 18
MIF −0.306 0.246 15
P-selectin −0.312 0.226 15
Uteroglobin −0.377 0.123 18
Correlations of normalised analyte concentrations to disease duration (*in years
since commencing treatment) were determined using Spearman’s rank correlation.
Following correction for multiple testing using Bonferroni’s method, a p-value
of < 0.0017 was considered significant (highlighted in bold). rs: Spearman
correlation coefficient. N: number of correlation pairs
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HGF levels were negatively associated with disease
duration since commencing treatment in POAG sam-
ples, indicating a reduction of HGF over time, which
may be linked to or independent from treatment for
hypertension. HGF plays a role in tissue repair, and is
therefore closely linked to inflammation [26]. HGF stim-
ulates proliferation, migration and differentiation of
many cell types, including TM cells [44], and can stimu-
late MMP activity in endothelial cells [45]. In this study,
the number of samples where HGF was above a set
threshold of detection was analysed between the POAG
and cataract group (Table 2, p = 0.003); whilst this com-
parison did not pass correction for multiple testing, the
result is in line with published literature, showing a signifi-
cant increase in HGF in glaucomatous aqueous humor in
relation to cataract samples [26]. It has been suggested
that elevated HGF levels in glaucomatous aqueous humor
may play a compensatory role, by increasing aqueous
humor outflow, or aiding in repairing TM damage [26].
The correlation suggests that this compensation may be
lost over time.
Similar to uteroglobin, FLRG correlated positively with
age in POAG but not cataract. FLRG is a secreted glyco-
protein highly homologous to follistatin [46] that binds
to and thereby inactivates members of the TGFβ super-
family, including activin A and BMP2, by disabling their
ability to interact with cell surface receptors [37]. Inter-
estingly, whilst FLRG was measurable, follistatin was not
detected in any of the samples analysed in this study.
Within the anterior segment, FLRG may be involved in
the regulation of BMP2-induced calcification of the tra-
becular ECM, which has been suggested to occur with
age and to be more prominent in glaucomatous TM [8].
The correlation of FLRG with age may indicate a greater
need for BMP-2 inhibition, due to increased calcifica-
tion. BMP2-induced calcification of the TM has been
shown to directly lead to elevated IOP in a POAG rat
model [8] and also agrees with existing reports of in-
creased TM stiffness in POAG [7].
Whilst several correlations were determined between
analytes and disease descriptors at a significance threshold
of p = 0.05, six out of nine did not pass correction for mul-
tiple testing (adjusted p = 0.0017), but may do so in other
appropriately powered studies. Although this study did not
include a replication cohort, each analyte measured was
selected from either discovery-based proteomic stud-
ies or immunoassay-based results reported by other
groups [12, 16, 24–28]. Despite this, we were unable to
detect many of the proteins included in this study at levels
above the lower limit of our standard curves. Aside from
technical limitations of our chosen multiplex immuno-
assay, contributing factors many include the variation in
proteins identified across multiple proteomic studies
[16, 20], as well as the wide spread of specific analyte
concentrations observed between aqueous humor samples
from different individuals, as reported in some studies [47].
It is important to note that some topical treatments
commonly used to treat ocular hypertension, such as
latanoprost and brimonidine, may contribute to aqueous
inflammation [48, 49]. Whilst the potential effects of
such medication on the protein concentrations discussed
here are not specifically known, altered aqueous humor
concentrations of other proteins have been reported
[50]. Although there were no differences between the
normalised analyte concentrations measured in POAG
and cataract for the 6 analytes studied here, the potential
contributions from patient medications to the associa-
tions reported here cannot be excluded.
Conclusion
In conclusion, this study has expanded our knowledge of
aqueous humor composition by providing quantitative
measures for four proteins previously undetermined for
aqueous humor. The correlations of Uteroglobin and
FLRG with age in POAG may suggest an increased need
for compensation of inflammatory and calcifying activity
in the ageing glaucomatous TM to maintain functionality,
but at present it is unclear whether these proteins play a
causative or compensatory role. If any or all of these pro-
teins are to have clinical utility, be it as a diagnostic bio-
marker or therapeutic target, further research is needed to
define their contributions to TM cell physiology, particu-
larly in respect to aqueous humor inflammation and TM
outflow resistance, and to determine if these proteins have
roles in the onset and progression of POAG.
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Additional file 1: This file contains Supplementary Tables S1 to S5, which
report correlations to relevant clinical descriptors in the cataract and POAG
groups. (DOCX 32 kb)
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